This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MetLife (MET) Collaborates With Savi to Aid Students With Debts
by Zacks Equity Research
MetLife's (MET) Upwise partners with Savi to help students better understand the loan payment process and loan forgiveness eligibility criteria.
Reasons to Hold American International (AIG) Stock for Now
by Zacks Equity Research
Strong General Insurance business, improving premiums and cost-cutting efforts poise American International (AIG) well for growth.
Aflac (AFL) Adds Beneficiary Services to Product Portfolio
by Zacks Equity Research
Aflac (AFL) takes the help of Iris to integrate the Beneficiary Companion service within its life, absence and disability product offerings to ease survivors in settling final affairs post the death of a loved one.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from solid performance of automotive and other insurance marketplace verticals and higher consumer traffic.
Here's Why You Should Add Lemonade (LMND) to Your Kitty
by Zacks Equity Research
Lemonade (LMND) stands to gain from improvement in premium per customer, continued shift in the mix of underlying products toward higher value policies and higher instalment fees.
The Zacks Analyst Blog Highlights Avis Budget, RenaissanceRe, CNO Financial, Everest Re and Reliance Steel & Aluminum
by Zacks Equity Research
Avis Budget, RenaissanceRe, CNO Financial, Everest Re and Reliance Steel & Aluminum are included in this Analyst Blog.
Are Investors Undervaluing CNO Financial Group (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Value Stocks to Buy for Safety Amid Market Volatility
by Nalak Das
We have narrowed our search to five value stocks. These are: CAR, RNR, RE, RS, CNO.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Why Investors Should Invest in CNO Financial (CNO) Stock Now
by Zacks Equity Research
Strong direct-to-consumer life sales, improving annuity collected premiums and increased Medicare enrolment poise CNO Financial (CNO) well for growth.
MetLife (MET) Forms $4B Agriculture Mortgage Loans in 2022
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, supports agricultural producers by initiating $4 billion of agricultural mortgage loans across 400 notes in 2022.
MetLife (MET) Originates $15.1 billion in Private Placement Debt
by Zacks Equity Research
Issuers turning to private debt will increase private placement assets under MetLife's (MET) asset management arm, boosting management fees.
Is CNO Financial Group (CNO) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why CNO Financial (CNO) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
CNO (CNO) Down 3.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aflac (AFL) Adds Features to Enrich Hospital Insurance Product
by Zacks Equity Research
Aflac (AFL) launches an upgraded version of its Hospital Insurance product - Aflac Choice for offering mental health coverage and hospital confinement benefits to policyholders.
Best Momentum Stock to Buy for March 6th
by Zacks Equity Research
SVC, DTEGY and CNO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 6, 2023.
MetLife's (MET) Asset Management Unit Acquires Raven Capital
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, acquires Raven Capital with $2.1 billion in assets under management, aiming to expand its offerings in private credit.
Best Momentum Stock to Buy for March 2nd
by Zacks Equity Research
BHF, CNO and AAON made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 2, 2023.
Best Value Stocks to Buy for March 2nd
by Zacks Equity Research
CNO and GIC made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 2, 2023.
New Strong Buy Stocks for March 2nd
by Zacks Equity Research
PUBGY, MELI, CNO, AIQUY and WPP have been added to the Zacks Rank #1 (Strong Buy) List on March 2, 2023.
Is CNO Financial Group (CNO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CNO Financial (CNO) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
AMERISAFE (AMSF) Q4 Earnings Beat, Hikes Dividend by 10%
by Zacks Equity Research
AMERISAFE's (AMSF) fourth-quarter earnings reflect solid underwriting results. Management approved a 9.7% rise in the quarterly cash dividend.
Are Investors Undervaluing Ageas (AGESY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.